NVO – Novo Nordisk A/S
NVO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.73
Margin Of Safety %
24
Put/Call OI Ratio
0.77
EPS Next Q Diff
4.09
EPS Last/This Y
17.56
EPS This/Next Y
0.41
Price
36.03
Target Price
47.71
Analyst Recom
2.56
Performance Q
-31.43
Upside
25.2%
Beta
0.75
Ticker: NVO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | NVO | 37.47 | 0.72 | 0.45 | 1576372 |
| 2026-03-03 | NVO | 36.66 | 0.72 | 0.77 | 1568494 |
| 2026-03-04 | NVO | 38.45 | 0.72 | 0.50 | 1617740 |
| 2026-03-06 | NVO | 38.6 | 0.72 | 0.47 | 1684708 |
| 2026-03-09 | NVO | 39.82 | 0.73 | 0.25 | 1621827 |
| 2026-03-10 | NVO | 38.72 | 0.72 | 0.36 | 1637122 |
| 2026-03-11 | NVO | 38.85 | 0.72 | 0.46 | 1662327 |
| 2026-03-12 | NVO | 38.03 | 0.72 | 1.44 | 1677403 |
| 2026-03-13 | NVO | 38.02 | 0.72 | 1.92 | 1677403 |
| 2026-03-17 | NVO | 38.44 | 0.72 | 0.60 | 1666581 |
| 2026-03-18 | NVO | 37.47 | 0.72 | 0.63 | 1676885 |
| 2026-03-20 | NVO | 36.49 | 0.71 | 0.68 | 1717087 |
| 2026-03-25 | NVO | 36.35 | 0.76 | 1.60 | 1521307 |
| 2026-03-26 | NVO | 36.4 | 0.78 | 0.42 | 1548195 |
| 2026-03-27 | NVO | 36.07 | 0.77 | 0.59 | 1594485 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | NVO | 37.46 | -24.4 | -5914.6 | 21.05 |
| 2026-03-02 | NVO | 37.75 | -24.4 | -1627.7 | 21.05 |
| 2026-03-03 | NVO | 36.70 | -24.4 | -2372.3 | 21.05 |
| 2026-03-04 | NVO | 38.44 | -24.4 | -1105.7 | 21.05 |
| 2026-03-05 | NVO | 39.06 | 0.6 | -1871.2 | 21.05 |
| 2026-03-06 | NVO | 38.58 | 0.6 | -2339.9 | 21.05 |
| 2026-03-09 | NVO | 39.81 | 0.6 | -1903.2 | 21.05 |
| 2026-03-10 | NVO | 38.75 | 0.6 | -2728.2 | 21.05 |
| 2026-03-11 | NVO | 38.85 | 0.6 | -2164.7 | 21.05 |
| 2026-03-12 | NVO | 38.03 | 0.6 | -2729.5 | 21.05 |
| 2026-03-13 | NVO | 37.98 | 0.6 | -2535.4 | 21.05 |
| 2026-03-17 | NVO | 38.44 | 0.6 | -2361.5 | 21.05 |
| 2026-03-18 | NVO | 37.49 | 0.6 | -3113.7 | 21.05 |
| 2026-03-19 | NVO | 37.07 | 0.6 | -2780.1 | 21.05 |
| 2026-03-20 | NVO | 36.53 | 0.6 | -2774.0 | 21.05 |
| 2026-03-23 | NVO | 36.83 | 0.6 | -2601.1 | 21.05 |
| 2026-03-24 | NVO | 36.89 | 0.6 | -2575.7 | 21.21 |
| 2026-03-25 | NVO | 36.34 | 0.6 | -2696.7 | 21.21 |
| 2026-03-26 | NVO | 36.38 | 0.6 | -2479.4 | 21.21 |
| 2026-03-27 | NVO | 36.03 | 0.6 | -2834.9 | 21.21 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | NVO | 0.00 | -0.10 | 0.80 |
| 2026-03-02 | NVO | 0.00 | -0.41 | 0.80 |
| 2026-03-03 | NVO | 0.00 | -0.41 | 0.80 |
| 2026-03-04 | NVO | 0.00 | -0.41 | 0.80 |
| 2026-03-05 | NVO | 0.00 | -0.41 | 0.80 |
| 2026-03-06 | NVO | 0.00 | -0.41 | 0.80 |
| 2026-03-09 | NVO | 0.00 | -0.40 | 0.80 |
| 2026-03-10 | NVO | 0.00 | -0.40 | 0.80 |
| 2026-03-11 | NVO | 0.00 | -0.40 | 0.84 |
| 2026-03-12 | NVO | 0.00 | -0.40 | 0.84 |
| 2026-03-13 | NVO | 0.00 | -0.40 | 0.84 |
| 2026-03-17 | NVO | 0.00 | -0.32 | 0.84 |
| 2026-03-18 | NVO | 0.00 | -0.32 | 0.84 |
| 2026-03-19 | NVO | 0.00 | -0.32 | 0.84 |
| 2026-03-20 | NVO | 0.00 | -0.32 | 0.84 |
| 2026-03-23 | NVO | 0.00 | 0.03 | 0.84 |
| 2026-03-24 | NVO | 0.00 | 0.03 | 0.84 |
| 2026-03-25 | NVO | 0.00 | 0.03 | 0.73 |
| 2026-03-26 | NVO | 0.00 | 0.03 | 0.73 |
| 2026-03-27 | NVO | 0.00 | 0.03 | 0.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1
Avg. EPS Est. Current Quarter
6.57
Avg. EPS Est. Next Quarter
5.09
Insider Transactions
Institutional Transactions
0.03
Beta
0.75
Average Sales Estimate Current Quarter
74710
Average Sales Estimate Next Quarter
71628
Fair Value
44.85
Quality Score
98
Growth Score
83
Sentiment Score
38
Actual DrawDown %
75.7
Max Drawdown 5-Year %
-75.3
Target Price
47.71
P/E
10.39
Forward P/E
10.84
PEG
P/S
2.6
P/B
5.25
P/Free Cash Flow
13.57
EPS
3.47
Average EPS Est. Cur. Y
21.21
EPS Next Y. (Est.)
21.62
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
33.03
Relative Volume
0.61
Return on Equity vs Sector %
25.4
Return on Equity vs Industry %
16.1
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.08
EBIT Estimation
-2834.9
◆
NVO
Healthcare
$36.04
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
30.2
Range 1M
4.5%
Sup Dist
0.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-11.4%
EPS NY
3.1%
52W%
0.4%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+353.8% upside
Upside
+353.8%
Quality
98
MoS
24%
Novo Nordisk A/SSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68794
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
NVO
Latest News
—
Caricamento notizie per NVO…
stock quote shares NVO – Novo Nordisk A/S Stock Price stock today
news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025
marketwatch NVO – Novo Nordisk A/S yahoo finance google finance
stock history NVO – Novo Nordisk A/S invest stock market
stock prices NVO premarket after hours
ticker NVO fair value insiders trading